Name : Galxe (GAL)
GAL Price : $1.867 -9.93%
Consensus Mechanism : ERC-20 & BEP-20
Volume: 480,233
Market Cap: 14,839,417
Shariah Judgement
This feature only can be accessed by subscribed users.
Shariah Status :
Last Screening: Q2 2024
Legitimacy:
Project:
Token:
Reward:
Shariah
Legitimacy
People
Shariah Analysis
Project/Products | Use Case | Status |
---|---|---|
Use Case | Status |
---|---|
System | Status | Interpretation |
---|---|---|
Legitimacy Analysis
Details | Status | |
---|---|---|
Whitepaper | ||
Project |
People Analysis
Details | Status | |
---|---|---|
Team |
Strong
Strong
Strong
Strong
Strong
Strong
Strong
Strong
Strong
Strong
Strong
Strong
Strong
Strong
Neutral
Neutral
Neutral
Neutral
Neutral
Neutral
Neutral
Neutral
Neutral
Neutral
Neutral
Neutral
Neutral
Neutral
Weak
Weak
Weak
Weak
Weak
Weak
Weak
Weak
Weak
Weak
Weak
Weak
Weak
Weak
Overview
Galxe Protocol, launched on April 28, 2022, via Binance Launchpool, revolutionizes credential issuance and verification in the Web3 sphere. It offers users complete control over their private data and identity through a cutting-edge system. Galxe serves as the premier Web3 credential data network, fostering collaboration and innovation among developers and projects. Using open infrastructure, it incentivizes data curators while ensuring user privacy through Zero-Knowledge Proof technology. Galxe Protocol empowers individuals to securely manage and share verifiable credentials while offering builders opportunities to create diverse applications, from Sybil prevention algorithms to decentralized review systems.
Whitepaper & Documents
Sharlife uses TradingView technology to present price information through charts. TradingView serves as a charting platform catering to a worldwide community of traders and investors. With robust support across browsers, desktops, and mobile applications, the platform offers exceptional access to real-time data such as Dow Futures and BTC USD Chart, as well as the latest news, financial reports, stock screener, and economic .
COMMENTS
0 Comments